Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
BUSINESS
As BMS Closes Celgene Buy, Japan Integration Gets Underway; 132 Otezla Staffers to Move to Amgen JV
Bristol-Myers Squibb completed its US$74 billion takeover of Celgene on November 20 after clearing the final regulatory hurdle late last week with the US Federal Trade Commission (FTC) nod, opening the way for their global integration including in the Japanese…
To read the full story
Related Article
- Amgen Takes Over Japan MA for Otezla
July 7, 2020
- Bristol-Myers Japan Chief Doubles as Celgene President amid Transition
January 10, 2020
BUSINESS
- Tanabe to Wind Down NeuroDerm, Scrap EU Launch of Parkinson’s Drug
November 19, 2026
- Shionogi Narrows R&D Pipeline to 21 Priority Programs Across 3 Disease Areas
November 19, 2026
- Toho, SDF Hospital Conduct Emergency Drug Supply Drill
November 19, 2026
- Japan Clears Fujirebio’s Blood-Based Aβ42 Test for Alzheimer’s
November 19, 2026
- Sobi Japan to Take Over Orfadin from Astellas in December
November 19, 2026





